Wei Wu,

Principal, Venture Investments

  • Focus: Pharmaceutical, Medical Devices, Consumer Health
  • Based in Shanghai, China
  • Fun fact: Enjoys Latin dance and playing piano in her spare time

Wei is Principal, Venture Investments at Johnson & Johnson Innovation ­­– JJDC, Inc. (JJDC), where she initiates and manages equity investments to drive innovation and fuel new and sustainable businesses.  Based at the Asia-Pacific Innovation Center, Wei focuses on fostering innovation across the region for all three sectors of Johnson & Johnson.

Prior to joining JJDC, Wei was a Senior Associate at Illumina Ventures with a focus on genomics-enabled precision medicine including therapeutics, diagnostics, and life science tools. Prior to that, she was the Director of Healthcare Investment and Business Development of BOE Ventures where she focused on VC fund investment, direct investment, and business development opportunities at the intersection of technology and life sciences, including digital health and medical devices. Wei was a Co-chair of the Biotech and Genomics Investment Committee of Life Science Angels that invest in seed-stage opportunities in the broad life science industry. Before becoming an investor, Wei was an R&D project lead at NuGEN Technologies (later TECAN Genomics).

Wei received her Ph.D. from UCLA in Biological Chemistry and completed her postdoctoral research in the Department of Pathology at Stanford University. She received a Bachelor of Science in Biological Sciences from Peking University, China. She was trained by two National Academy of Sciences members and published in journals including Cell, Nature, Neuron, and Nature Reviews Genetics. She was a Bronze Medalist of the 12th International Biology Olympiad.

Wei Wu
Wei Wu